Stay updated on PD1-LAG3 Bispecific Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page.

Latest updates to the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page
- Check3 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a new site version was applied to render this page.SummaryDifference0.0%

- Check11 days agoChange DetectedThe footer revision label changed from v3.6.0 to v3.6.2, indicating a site software update rather than changes to the study history content.SummaryDifference0.0%

- Check18 days agoChange DetectedA new study version (73) was posted on 2026-06-15, updating the Study Status in the record history. A follow-up entry on 2026-06-16 reinforces the current status, and a deletion on 2026-03-18 removes prior data from the history.SummaryDifference0.2%

- Check25 days agoChange DetectedThe study history now shows that recruitment has ended, reflecting no longer looking for participants; the record history also updates to version v3.6.0 (replacing v3.5.5).SummaryDifference0.2%

- Check32 days agoChange DetectedA new revision entry (v3.5.5) was added to the page's history and the prior revision (v3.5.4) was removed, reflecting a small update in the page's version history.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page's revision label updated from v3.5.3 to v3.5.4, indicating an administrative software update to the site. This does not reflect changes to the trial data or core content.SummaryDifference0.0%

Stay in the know with updates to PD1-LAG3 Bispecific Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page.